Science and Research

ROSE

Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study

Study details
Study-ID: NCT05089916, 2020-003512-27
Study-ID: NCT05089916, 2020-003512-27
DZL Disease Area: LC
DZL Disease Area: LC
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL Investigator Initiated Trial, DZL recruiting center
DZL Role: DZL Investigator Initiated Trial, DZL recruiting center
Funding: Externally - public
Funding: Externally - public
DZL Participating Sites: CPC-M, TLRC, BIH / Charité - Associated Partner
DZL Participating Sites: CPC-M, TLRC, BIH / Charité - Associated Partner
Start Date: 20.01.2022
Completion Date: 31.12.2027
Status: Recruiting
Status: Recruiting
DZL Investigator Initiated Trial, DZL recruiting center
Link to Study


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.